Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib combined with chemotherapy for advanced malignant solid tumors (SD patients)
ChiCTR-OPC-16009849Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Oct 2016
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Rivoceranib in Non-hematologic malignancy, sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: disease control rate. Started Oct 2016; status: recruiting.
02
Drugs
Rivoceranib
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on ChiCTR-OPC-16009849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16009849.